This content is from: Premium

Hedge Funds Go Bottom Fishing in Biopharma

Over the past few weeks, four different life sciences hedge funds have taken stakes of at least 5 percent in more than a half dozen stocks.

Is it time to buy?That’s the number-one question facing investors as the stock indices sink ever deeper into bear market territory.One group of investors who have been aggressively making big bets, however, are the managers who specialize in biopharma and life sciences stocks. Over the past few weeks, four different

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content